0
Y-mAbs Therapeutics, Inc. Banner Image

Y-mAbs Therapeutics, Inc. has reached its limit for free report views

Work for Y-mAbs Therapeutics, Inc.? Upgrade Your Profile and unlock all your annual reports.

Y-mAbs Therapeutics, Inc.

  • Ticker YMAB
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Y-mAbs Therapeutics, Inc. Logo Image
  • 51-200 Employees
  • Based in New York City, New York
Y-mAbs is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. The Company has a broad and advanced product pipeline, including two pivotal-stage product candidates naxitamab and omburtamab—which target tumors that express GD2 and B7-H3, respectively.
Y-mAbs Therapeutics, Inc.

Most Recent Annual Report

Y-mAbs Therapeutics, Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Y-mAbs Therapeutics, Inc. has reached its limit for free report views.

Older/Archived Annual Reports